These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9149127)

  • 1. Promoting activity of 3-tert-butyl-4-hydroxyanisole (BHA) in BALB/3T3 cell transformation.
    Sakai A; Miyata N; Takahashi A
    Cancer Lett; 1997 May; 115(2):213-20. PubMed ID: 9149127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiating activity of 3-tert-butyl-4-hydroxyanisole (3-BHA) and its metabolites in two-stage transformation of BALB/3T3 cells.
    Sakai A; Miyata N; Takahashi A
    Carcinogenesis; 1990 Nov; 11(11):1985-8. PubMed ID: 2225330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid and butylated hydroxyanisole inhibit promoter-enhanced transformation in vitro.
    Saito M; Ohkawa Y; Inui N
    Cancer Lett; 1986 Nov; 33(2):161-5. PubMed ID: 3791186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,5-Di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration.
    Sakai A; Teshima R
    Cancer Lett; 2001 Jul; 168(2):183-90. PubMed ID: 11403923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butylated hydroxyanisole isomers induce distinct adipogenesis in 3T3-L1 cells.
    Sun Z; Yang X; Liu QS; Li C; Zhou Q; Fiedler H; Liao C; Zhang J; Jiang G
    J Hazard Mater; 2019 Nov; 379():120794. PubMed ID: 31238218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating activity of quinones in the two-stage transformation of BALB/3T3 cells.
    Sakai A; Miyata N; Takahashi A
    Carcinogenesis; 1995 Mar; 16(3):477-81. PubMed ID: 7697801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate.
    Kozumbo WJ; Seed JL; Kensler TW
    Cancer Res; 1983 Jun; 43(6):2555-9. PubMed ID: 6850576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of carcinogen identification in BALB/3T3 cell transformation by application of a 2-stage method.
    Sakai A; Sato M
    Mutat Res; 1989 Oct; 214(2):285-96. PubMed ID: 2797027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Nonylphenol acts as a promoter in the BALB/3T3 cell transformation.
    Sakai A
    Mutat Res; 2001 Jun; 493(1-2):161-6. PubMed ID: 11516725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of benzo[a]pyrene-induced morphological transformation of Syrian hamster embryo cells by butylated hydroxytoluene and butylated hydroxyanisole.
    Potenberg J; Schiffmann D; Kahl R; Hildebrandt AG; Henschler D
    Cancer Lett; 1986 Nov; 33(2):189-98. PubMed ID: 3791190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
    Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
    Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation.
    Komori A; Yatsunami J; Suganuma M; Okabe S; Abe S; Sakai A; Sasaki K; Fujiki H
    Cancer Res; 1993 May; 53(9):1982-5. PubMed ID: 8481899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro.
    Matsuoka A; Matsui M; Miyata N; Sofuni T; Ishidate M
    Mutat Res; 1990 Jun; 241(2):125-32. PubMed ID: 2345551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of quercetin on the transformation of BALB 3T3 cells.
    Tanaka K; Ono T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):819-25. PubMed ID: 3115928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
    Saito M; Sakagami H; Fujisawa S
    Anticancer Res; 2003; 23(6C):4693-701. PubMed ID: 14981915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of a third generation retinoid R8923 and all-trans retinoic acid on two-stage chemical carcinogenesis of BALB/3T3-A31 cells in vitro].
    Guo CY; Han R
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):163-6. PubMed ID: 7956690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthovanadate, an inhibitor of protein tyrosine phosphatases, acts more potently as a promoter than as an initiator in the BALB/3T3 cell transformation.
    Sakai A
    Carcinogenesis; 1997 Jul; 18(7):1395-9. PubMed ID: 9230286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay.
    Sighinolfi GL; Artoni E; Gatti AM; Corsi L
    Environ Toxicol; 2016 May; 31(5):509-19. PubMed ID: 25358123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay.
    Tsuchiya T; Tanaka-Kagawa T; Jinno H; Tokunaga H; Sakimoto K; Ando M; Umeda M
    Toxicol Sci; 2005 Apr; 84(2):344-51. PubMed ID: 15647599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are free radicals involved in tumor promotion?
    Kozumbo WJ; Trush MA; Kensler TW
    Chem Biol Interact; 1985 Jul; 54(2):199-207. PubMed ID: 2992824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.